Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

product development

4 posts
UUBS
UBS Lifts Etsy Price Target to $72: Has the Beaten-Down E-Commerce Name Finally Bottomed?
Read More

UBS Lifts Etsy Price Target to $72: Has the Beaten-Down E-Commerce Name Finally Bottomed?

  • 2026-04-28
courtesy of Etsy Inc. Quick Read Etsy (ETSY) received a price target increase to $72 from $53 from…
UUBS
UBS Lifts Etsy Price Target to $72: Has the Beaten-Down E-Commerce Name Finally Bottomed?
Read More

UBS Lifts Etsy Price Target to $72: Has the Beaten-Down E-Commerce Name Finally Bottomed?

  • 2026-04-28
Quick Read Etsy (ETSY) received a price target increase to $72 from $53 from UBS analyst Stephen Ju,…
BBasel
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
Read More

Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420

  • 2026-04-09
Basilea Pharmaceutica International Ltd, Allschwil Funding is awarded following successful completion of IND-enabling studies and clinical study authorization …
NNovartis
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
Read More

SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease

  • 2026-03-15
ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro Pharmaceuticals Logo (PRNewsfoto/SciNeuro Pharmaceuticals) SciNeuro grants Novartis an exclusive worldwide…
Switzerland
www.europesays.com